Literature DB >> 1683897

Ropinirole (SK and F 101468) in the treatment of Parkinson's disease.

B Kleedorfer, G M Stern, A J Lees, J M Bottomley, N Sree-Haran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1683897      PMCID： PMC1014589          DOI： 10.1136/jnnp.54.10.938

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes.

Authors:  R Barker; J Duncan; A Lees
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

2.  Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468.

Authors:  R Kapoon; Z Pirtosek; J P Frankel; G M Stern; A J Lees; J M Bottomley; N S Haran
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

3.  The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.

Authors:  J G Nutt; W R Woodward; J P Hammerstad; J H Carter; J L Anderson
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

4.  Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.

Authors:  P A Kempster; J P Frankel; M Bovingdon; R Webster; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154
  4 in total
  1 in total

1.  Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

Authors:  C Brefel; C Thalamas; S Rayet; A Lopez-Gil; K Fitzpatrick; S Bullman; D R Citerone; A C Taylor; J L Montastruc; O Rascol
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.